Skip to main content

Table 3 Plasma cholesterol and triacylglycerol in hamsters treated with G. lucidum and lovastatin (mmol/L)

From: Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs

Group TC TC TAG TAG VLDL LDL HDL LDL/HDL
  D1 D18 D1 D18 D18 D18 D18 D18
Control 3.57 3.48 1.10 1.08 0.22 0.51 2.75 0.19
Lovastatin 3.39 3.16a 1.07 0.98 0.18a* 0.48 2.50a 0.19
Gl (2.5%) 3.46 3.40 0.64a 0.90a 0.18 0.53 2.69 0.20
Gl (5%) 3.34 3.14a* 0.89a* 0.92a 0.20 0.49 2.44a* 0.20
  1. TC, total cholesterol; TAG, triacylglycerol; VLDL, LDL, HDL, very low-, low-, and high-density lipoproteins; D, day; LOVA, 20 mg/kg diet. Values represent mean of 6 animals. aSignificantly different from the control (P < 0.05 or *P < 0.10), students, unpaired, 1-tailed,t-test, equal variances.